The CytRx oncology pipeline is focused on the clinical development of aldoxorubicin (formerly known as INNO-206), its improved version of the widely used chemotherapeutic agent doxorubicin. Now it says ytRx Corporation is a biopharmaceutical research and development company specializing in oncology. CytRx currently is focused on the clinical development of aldoxorubicin (formerly known as INNO-206), its improved version of the widely used chemotherapeutic agent doxorubicin.
Notice the word: Currently....not is, but currently.
I feel duped already.
Somehow the word got out for real and we may be screewed. I thought we would here this at Oppenheimer. I received an email saying they were still going to perform at Opp, I wonder if that was a freaking LIE like all the B.S. I received from them today.
The only reason they would release it earlier than the openheimer is if it was leaked.and IF it was leaked,then it must not be good because if it was good I have a hard time believing we sold off like that today..thats messed up.i think we are in for a long ride down tomorrow and that is just my gut.this blows.